Nuwellis Acquisition | Technology Deal in MN

Nuwellis has completed the acquisition of Rendiatech, a medical devices business in Minnesota, for $2.4 million. The Nuwellis acquisition adds automated kidney-function monitoring capabilities to support cardiorenal medical device development, including Aquadex therapy system placements and utilization. As part of the medical devices acquisition, Nuwellis expands pediatric and critical care capabilities tied to ultrafiltration and extracorporeal therapy workflows in MN. The add on acquisition is part of technology M&A and technology deals MN strategy to broaden the cardiorenal continuum, with deal consideration reported across multiple amounts totaling under $10 million.